For instance, in colorectal cancer, inhibiting specific molecules such as ADAM17 and soluble JAGGED-1 is associated with the disruption of angiocrine signaling, further supporting the view that targeting these pathways can mitigate tumor-promoting effects 277, 278. The gene discussed is ADAM17; the disease is colorectal cancer.